Circadian REV-ERBs Repress E4bp4 to Activate NAMPT-dependent NAD+ Biosynthesis and Sustain Cardiac Function
Pieterjan Dierickx,Kun Zhu,Bryce J. Carpenter,Chunjie Jiang,Marit W. Vermunt,Yang Xiao,Timothy S. Luongo,Tsunehisa Yamamoto,Íngrid Martí-Pàmies,Sobuj Mia,Mary Latimer,Abhinav Diwan,Juanjuan Zhao,Amy K. Hauck,Brianna Krusen,Hoang C. B. Nguyen,Gerd A. Blobel,Daniel P. Kelly,Liming Pei,Joseph A. Baur,Martin E. Young,Mitchell A. Lazar
DOI: https://doi.org/10.1038/s44161-021-00001-9
2021-01-01
Nature Cardiovascular Research
Abstract:The heart is a highly metabolic organ that uses multiple energy sources to meet its demand for ATP production. Diurnal feeding-fasting cycles result in substrate availability fluctuations which, together with increased energetic demand during the active period, impose a need for rhythmic cardiac metabolism. The nuclear receptors REV-ERBα and β are essential repressive components of the molecular circadian clock and major regulators of metabolism. To investigate their role in the heart, here we generated mice with cardiomyocyte (CM)-specific deletion of both Rev-erbs, which died prematurely due to dilated cardiomyopathy. Loss of Rev-erbs markedly downregulated fatty acid oxidation genes prior to overt pathology, which was mediated by induction of the transcriptional repressor E4BP4, a direct target of cardiac REV-ERBs. E4BP4 directly controls circadian expression of Nampt and its biosynthetic product NAD+ via distal cis-regulatory elements. Thus, REV-ERB-mediated E4BP4 repression is required for Nampt expression and NAD+ production by the salvage pathway. Together, these results highlight the indispensable role of circadian REV-ERBs in cardiac gene expression, metabolic homeostasis and function.